Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as ...

U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...

Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...

"People come together, operators, with their supervisors at 6 a.m. every morning, and they talk about what issues they have and how they propose to solve it. Those get escalated through all levels of ...

(AP Photo/Amanda Andrade-Rhoades ... both the uninsured and people who have insurance that doesn’t cover the weight-loss ...

After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...

Eli Lilly plans to spend at least $27bn to build four new manufacturing plants in the United States, the drugmaker has said as it grapples with the threat of drug import duties from the Trump ...

The pharmaceutical firm is growing its presence across three states, creating 3,000 jobs.

(AP Photo/Amanda Andrade-Rhoades ... who have insurance that doesn’t cover the weight-loss drugs. Last week, Eli Lilly said it would cut the monthly price of its starter dose of Zepbound ...